RELMα establishes a permissive environment for influenza virus infection through direct effects on lung epithelial cells

Shirazi R
University of California Riverside
August 18, 2026
J Virol
https://pubmed.ncbi.nlm.nih.gov/42461031/

This article is currently being updated. View its version on PubMed.

https://pubmed.ncbi.nlm.nih.gov/42461031/

Research summary

The study investigates how RELMα influences influenza A virus infection in the lung. Using constitutive and cell-specific Retnla deficiency, the authors demonstrate that epithelial-derived RELMα creates an environment permissive to viral infection and directly increases susceptibility of lung epithelial cells to influenza virus.

Key outcome of the study

Retnla deficiency reduced infectious influenza virus burden in lung epithelial cells. Club cell-specific deletion reproduced this phenotype, supporting a direct epithelial role for RELMα. RELMα promoted influenza infection and altered epithelial cellular pathways that favor viral replication.

Model

Retnla conditional Knockout / reporter mouse — genOway-developed using Cre-Lox and FLEx technology, with Retnla exons 2–4 targeted and the deleted locus replaced by a tdTomato reporter. The conditional-ready Retnla^Flox/Flox allele enables cell-specific deletion and was crossed with CC10-CreERT for club cell-specific Retnla deletion. The model was also converted to constitutive Retnla deficiency for whole-body studies.

TARGET:
Retnla
Synonyms:
RELMα, RELM-alpha, FIZZ1, HIMF

Keywords

Influenza A virus, viral infection, respiratory disease, lung epithelium, host-pathogen interaction, antiviral immunity, epithelial cell biology

Technical specifications

Retnla conditional Knockout, Cre-Lox, FLEx technology, floxed exons 2–4, tdTomato reporter, cell-specific deletion, CC10-CreERT, club cells, constitutive deletion, influenza infection model

Related products

Catalogue product

No items found.

Customized product

Tissue-specific KO mouse

Use tissue- or cell-specific conditional Knockout mouse models to bypass embryonic lethality, compensatory mechanisms, complex phenotypes, etc.

Catalogue product

No items found.
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe